(RTTNews) – AstraZeneca stopped his trial of the complex COVID-19 vaccine due to a potentially unexplained illness on a British volunteer, reportedly posting an email sent by the company’s spokesman.
The vaccine is being developed through the pharmaceutical giant in partnership with the University of Oxford and is studied in thousands of patients in the United States and the United Kingdom.
The company reportedly stated that it had voluntarily suspended vaccination to allow for an independent review of protection data.
“This is a regimen action that will have to happen whenever there is a potentially unexplained illness in one of the trials, while it is being investigated, making sure to maintain the integrity of the trials,” said a corporate spokesperson.
On Tuesday, an organization of nine Covid-19 vaccine developers announced a historic commitment, underlining a united commitment to maintaining the integrity of the clinical procedure as reflected in the prospective global regulatory presentations and approvals of the first COVID-19 vaccines.
They must make transparent their continued commitment to future vaccines that oppose COVID-19 with the best moral criteria and sound clinical principles.
Vaccines are AstraZeneca, BioNTech, GlaxoSmithKline, Johnson